Prosecution Insights
Last updated: October 26, 2026

Jake Minh Vu, USPTO Patent Examiner

Listed by the USPTO as VU, JAKE MINH

Tech Center 1600 • Art Units: 1614 1618

This examiner grants 41% of resolved cases

Analysis

VU, JAKE MINH examines in Tech Center 1600 and Art Unit 1614. The record reflects 808 resolved cases, a 41.0% allowance rate, and a median of 1519 days to allowance. Interviews show a 27.0% lift. The combination indicates a prosecution setting where substantive claim positioning and direct examiner communication may both warrant significant attention.

Actinium Pharmaceuticals Inc., Boston Scientific Corporation, and Koninklijke Philips N.V. are the listed companies. The leading firms are Nixon Peabody LLP, THOMAS | HORSTEMEYER, LLP, and WOLF GREENFIELD & SACKS, P.C. Practitioners should account for the extended median path and develop a response strategy that addresses both allowance risk and timing.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

41.0%
Allow Rate
-19.0% vs TC avg
853
Total Applications
+27.0%
Interview Lift
1519
Avg Prosecution Days
Based on 808 resolved cases, 2023–2026

Rejection Statute Breakdown

0.6%
§101 Eligibility
20.8%
§102 Novelty
41.3%
§103 Obviousness
22.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18917556 BIODEGRADABLE DRUG ELUTING MICROSPHERE FOR THE TREATMENT OF SOLID TUMORS Non-Final OA Boston Scientific Scimed, Inc.
18267136 INSTANTLY GELLING COMPOSITIONS FOR ARTIFICIAL SALIVA AND ULTRASOUND GELS Non-Final OA KONINKLIJKE PHILIPS N.V.
18908883 METHOD TO RELIEVE STRESS IN CAPSULE SHELLS TO REDUCE PROPENSITY TO BREAK Non-Final OA R.P. Scherer Technologies, LLC
17414414 INDUCING FAVORABLE EFFECTS ON TUMOR MICROENVIRONMENT VIA ADMINISTRATION OF NANOPARTICLE COMPOSITIONS Non-Final OA Cornell University
18397190 METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES Non-Final OA BIOGEN MA INC.
16641059 SLIPPERY MICROPROPELLERS PENETRATE THE VITREOUS HUMOR Final Rejection Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Jake Minh Vu's allowance rate?

41.0% of resolved applications examined by Jake Minh Vu were allowed (808 resolved cases), compared with 47.9% across Art Unit 1614 over the last five years.

Does an interview help with examiner Jake Minh Vu?

This examiner's interview lift is +27.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Jake Minh Vu take to allow a patent?

Applications allowed by Jake Minh Vu took 1,519 days on average from filing to allowance.

Which art unit does examiner Jake Minh Vu work in?

Jake Minh Vu examines applications in Art Unit 1614 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month